… provide significant CyA at the ocular mucosa for extended periods … drug delivery properties
to the ocular surface would be a promising step towards the management of external ocular …

… This review will provide an overview on various conventional and novel ophthalmic drug
delivery systems developed to deliver drug to diseased ocular tissues for the treatment of ocular …

… Designing noninvasive sustained drug delivery systems and exploring the feasibility of topical
application to deliver drugs to the posterior segment may drastically improve drug delivery …

… barriers and protect the delivered drug from metabolic or immune attack, reduce drug toxicity,
and … Almost every class of topically or subconjunctivally applied ophthalmic drug has been …

… to deliver AmB onto the ocular surface. … drug delivery to be proposed as an ophthalmic
drug carrier, it is important to assay not only the biopharmaceutical properties but also the ocular …

… drug delivery … ocular drug delivery systems such as microemulsions, nanosuspensions,
nanoparticles, liposomes, niosomes, dendrimers, implants, and hydrogels. Potential for ocular …

… , and future challenges in ocular drug-delivery technologies. This expert opinion also
discusses the future challenges for ocular drug-delivery systems and the clinical translatable …

… Ocular iontophoresis offers a drug delivery system that is fast, painless and safe; and in
most cases, it results in the delivery of a high concentration of the drug to a specific site. …

… specific delivery. This review presents an overview of the various aspects of the ocular
drug delivery… , including structure of eye, its barriers, delivery routes and the challenges/limitations …

… to estimate the ocular residence time of drug delivery systems. In most studies not the amount
of delivery systems remaining on the ocular surface, but the amount of remaining drug, that …